Douglas E. Williams, Director at Ovid Therapeutics Inc. (OVID), bought 5,000 shares at $6.49 ($32K) on 2018-08-14, disclosed to the SEC on 2018-08-16.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| Filing → |
| CDAK | SELL | 2023-01-23 | $3K | — | Filing → |
| BIIB | SELL | 2015-06-22 | $1.6M | — | Filing → |
| BIIB | SELL | 2014-03-21 | $1.2M | — | Filing → |